Indefinite Delivery Contract HT942525DE004
- Not listed
- The Defense Health Agency awarded a single-award blanket purchase agreement to Hcsc Blood Center, operating as Miller-Keystone Blood Center, to supply blood products in support of healthcare programs. With a potential value of $6 million, the BPA enables ordering of blood components such as red blood cells, frozen plasma, and platelets through February 2025 at locations to be determined. No set-aside provisions were applied under the terms of this IDV, reflecting the Agency's need to fulfill its...
- The Defense Health Agency (DHA) awarded a single-award Indefinite Delivery Contract valued at $643,519.04 to Werfen USA LLC, a Bedford, Massachusetts-based manufacturer of in vitro diagnostic equipment and reagents, for the provision of blood bank reagents under a base contract period with four option years extending through September 30, 2027. The contract was awarded on April 1, 2023, following a solicitation posted on February 10, 2023, with a due date of March 13, 2023. No small business...
- The American National Red Cross has been awarded a single-award Blanket Purchase Agreement by the Defense Health Agency, valued at $7.5 million with a period of performance extending through September 30, 2029. This IDV authorizes the procurement of blood products, specifically low-titer O whole blood and liquid plasma, along with associated testing services. The contract carries no set-aside designation and was executed on October 1, 2024. As the prime contractor, the American Red Cross will...
- The Defense Health Agency awarded a blanket purchase agreement to Blood Centers of America, Inc. for the delivery of COVID-19 convalescent plasma. Under the single award agreement and associated task orders, Blood Centers of America will provide convalescent plasma valued at $8.789 million to support the Department of Defense's response to the COVID-19 pandemic. Performance will take place at Blood Centers of America's facility in Mosby, Virginia through November 30, 2021. The task orders issued...
- The Defense Health Agency (DHA), a defense agency, awarded a single-award Blanket Purchase Agreement (BPA) to the Republic of Korea National Red Cross, operating as the Gyeonggi Blood Center Red Cross, a non-profit organization. The $249,000, five-year BPA, established on July 1, 2022, enables the DHA and U.S. Army Medical Command to place firm-fixed-price orders for essential blood products, including apheresis platelets and whole blood units, to support U.S. military medical facilities in...
- The Defense Health Agency (DHA) has awarded a $500,000.00 Blanket Purchase Agreement (BPA) contract to Drk-Blutspendedienst Rheinland-Pfalz UND Saarland Gemeinnuetzige Gesellschaft MIT Beschraenkter Haftung, doing business as "Drk-Blutspendedienst Rheinland-Pfalz, Saarland," a for-profit organization based in Germany. The BPA, identified as contract number W9114F23A0003, is for the supply of blood bank supplies to support U.S. military healthcare facilities in Germany. The contract...
- The Defense Health Agency (DHA) awarded a Blanket Purchase Agreement (BPA) to The American National Red Cross, doing business as American Red Cross, for the supply of blood and blood products. The BPA has a ceiling value of $15,000,000 and an ultimate completion date of March 31, 2029. As a major supplier of blood and blood products to federal agencies, including the Department of Veterans Affairs (VA) and Department of Defense (DoD), the American Red Cross has been awarded several high-value...
- This Blanket Purchase Agreement (BPA) was awarded by the Defense Health Agency, a defense agency, to Werfen USA LLC, a manufacturer of in vitro diagnostic equipment, reagents, and services. The $2,000,000 single-award BPA has a period of performance through October 3, 2029 and is for the procurement of testing supplies for transfusion services. Werfen, as the prime contractor, will provide specialized medical devices, consumables, and support services to the Defense Health Agency, Department...
- This Blanket Purchase Agreement (BPA) contract was awarded by the Defense Health Agency (DHA) to Werfen USA LLC, a manufacturer and supplier of in vitro diagnostic equipment, reagents, and services. The $249,000 single-award BPA has an ultimate completion date of August 31, 2028 and is for the delivery of ROTEM-brand consumable laboratory products to support the agency's healthcare programs. Under this IDV, DHA has issued multiple firm fixed-price BPA calls to Werfen USA, a highly experienced...
- The Defense Health Agency Contracting Activity (DHACA) has awarded a single-award Blanket Purchase Agreement (BPA) to Lifestream Blood Bank, a non-profit organization based in San Bernardino, California, to provide blood and blood products to the Naval Hospital Twentynine Palms (NHTP) in California. This sole source contract, valued at up to $650,000 over a 5-year period from April 1, 2025 to March 31, 2030, will enable NHTP to maintain a consistent supply of critical blood products, including...
- HT942525DE004Indefinite Delivery Contract
- 1Federal Contract Awards
The Defense Health Agency (DHA) awarded a single-award Indefinite Delivery Contract to Octapharma USA Inc. (UEI: FKJKNJVR1HV4) on September 15, 2025, with a ceiling value of $14.88 million and an ultimate completion date of September 14, 2030. The contract procures Octaplas LG powder authorized under Food and Drug Administration Emergency Use Authorization, along with associated transfusion support materials including sterile water for injection, transfusion sets with filters, transfer sets, alcohol swabs, and vented spike adapters for blood type AB, with a minimum shelf-life requirement of 16 months. No small business set-aside was utilized in this procurement, which reflects DHA's ongoing requirement to maintain adequate blood and blood product inventory across military medical treatment facilities. The contract generated an initial delivery order issued on September 16, 2025, for 1,600 units of Octaplas LG kits valued at $1.6 million on a firm fixed-price basis, with performance scheduled to be completed by January 16, 2026 at Travis Air Force Base in Fairfield, California. Octaplas LG is a liquid plasma product used for transfusion to restore clotting factors and treat coagulopathy in medical settings. This delivery order represents a near-term supply need with compressed performance of approximately four months from award to completion, supporting DHA's mission to provide critical blood products necessary for patient care and operational readiness across the military health system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 9/16/25 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order HT942525DE004-HT942525FE062 | Octapharma USA Inc. | $1.6m | 9/16/25 | 1/16/26 | 9/16/25 |